Viral polymerase inhibitors

Disclosed is an isomer, enantiomers, diastereoisomer or tautomer of a compound represented by formula I wherein A is N, B is C and the rest of the substituents are disclosed within the specification. Also disclosed is the above compound for use as a inhibitor of RNA dependent RNA polymerase, specifi...

Full description

Saved in:
Bibliographic Details
Main Authors CHABOT, CATHERINE, POUPART, MARC-ANDRE, JOLICOEUR, ERIC, KAWAI, STEPHEN, BEAULIEU, PIERRE L, TSANTRIZOS, YOULA S, BROCHU, CHRISTIAN
Format Patent
LanguageEnglish
Published 31.03.2009
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed is an isomer, enantiomers, diastereoisomer or tautomer of a compound represented by formula I wherein A is N, B is C and the rest of the substituents are disclosed within the specification. Also disclosed is the above compound for use as a inhibitor of RNA dependent RNA polymerase, specifically as an inhibitor of HCV polymerase.
Bibliography:Application Number: NZ20040541852